Consult the medical resource doctors trust

UpToDate is one of the most respected evidence-based medical information resources in the world, used by over 400,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Epidemiology and risk factors for breast cancer

INTRODUCTION

In the US, breast cancer is the most common female cancer, the second most common cause of cancer death in women, and the main cause of death in women ages 40 to 59. About one-half of cases can be explained by known risk factors, such as age at menarche, first live birth, menopause, and proliferative breast disease. An additional 10 percent are associated with a positive family history.

Understanding the risk factors for breast cancer permits us to identify women at increased risk and intervene to modify risk, both individually and societally.

EPIDEMIOLOGY

Incidence — Annually, approximately 182,460 American women are diagnosed with breast cancer, and 40,480 die from the disease [1]. The lifetime probability of developing breast cancer is one in six overall (one in eight for invasive disease) [2].

In the early 1980s, breast cancer rates rose steeply by 3.7 percent per year over the baseline incidence. This was most likely the result of increasing use of screening mammography, since the incidence of ductal carcinoma in situ (DCIS) and stage I carcinomas increased, while that of higher stages either decreased or remained stable.

Data collected by the SEER program between 1992 and 1998 suggested that the incidence of estrogen (ER) and/or progesterone (PR) receptor-negative breast cancer was declining while that of ER/PR-positive disease was increasing [3]. At least some of this increase might be attributable to the use of hormone therapy (HT) in the 1980s and 1990s, since HT may preferentially increase the risk of ER/PR-positive tumors [4].

» To continue reading this article you need to login or subscribe.

Ready to join over 400,000 satisfied users? Subscribe to read this article and others like it.
Last literature review version 18.2: May 2010
This topic last updated: May 20, 2010
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References
Top
  1. Jemal, A, Siegel, R, Ward, E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225.
  2. seer.cancer.gov/csr/1975_2000/results_merged/topic_lifetime_risk.pdf.
  3. Li, CI, Daling, JR, Malone, KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003; 21:28.
  4. Chen, WY, Hankinson, SE, Schnitt, SJ, et al. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004; 101:1490.
  5. Li, et al. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003; 289:1421.
  6. Chen, CL, Weiss, NS, Newcomb, P, et al. Hormone replacement therapy in relation to breast cancer. JAMA 2002; 287:734.
  7. Li, CI, Malone, KE, Porter, PL, Weiss, NS. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003; 289:3254.
  8. Ravdin, PM, Cronin, KA, Howlader, N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007; 356:1670.
  9. Breen, N, A Cronin, K, Meissner, HI, et al. Reported drop in mammography: is this cause for concern?. Cancer 2007; 109:2405.
  10. Glass, AG, Lacey, JV Jr, Carreon, JD, Hoover, RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99:1152.
  11. Robbins, AS, Clarke, CA. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol 2007; 25:3437.
  12. Chlebowski, RT, Kuller, LH, Prentice, RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009; 360:573.
  13. Marshall, SF, Clarke, CA, Deapen, D, et al. Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. Breast Cancer Res 2010; 12:R4.
  14. Parkin, DM, Bray, F, Ferlay, J, Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74.
  15. Willett, WC, Rockhill, B, Hankinson, SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, Harris, JR, Lippman, ME, Morrow, M, Osborne, CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004, 3rd ed, p.223.
  16. Berry, DA, Cronin, KA, Plevritis, SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353:1784.
  17. American Cancer Society Breast Cancer Facts and Figures 2008 available online at www.cancer.org/docroot/STT/STT_0.asp (accessed April 15, 2008).
  18. Jatoi, I, Chen, BE, Anderson, WF, Rosenberg, PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007; 25:1683.
  19. Data on SEER (Surveillance, Epidemiology and End Results) cancer statistics available online at http://seer.cancer.gov/csr/1975_2003/results_merged/sect_04_breast.pdf (accessed October 11, 2006).
  20. Peto, J, Mack, TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000; 26:411.
  21. Pike, MC, Spicer, DV, Dahmoush, L, Press, MF. Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 1993; 15:17.
  22. Jemal, A, Thun, MJ, Ries, LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100:1672.
  23. Bradley, CJ, Given, CW, Roberts, C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002; 94:490.
  24. Palmer, JR, Wise, LA, Horton, NJ, et al. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 2003; 95:478.
  25. Carey, LA, Perou, CM, Livasy, CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492.
  26. Worsham, MJ, Raju, U, Lu, M, et al. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res 2007; 13:5474.
  27. Degnim, AC, Visscher, DW, Berman, HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007; 25:2671.
  28. Fisher, B, Dignam, J, Wolmark, N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999; 353:1993.
  29. Kelsey, JL, Fischer, DB, Holford, TR, et al. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 1981; 67:327.
  30. Whittemore, AS. Breast cancer in Marin County. Breast Cancer Res 2003; 5:232.
  31. Kulldorff, M, Feuer, EJ, Miller, BA, Freedman, LS. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol 1997; 146:161.
  32. Vieira, V, Webster, T, Weinberg, J, et al. Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data. Environ Health 2005; 4:11.
  33. Sturgeon, SR, Schairer, C, Gail, M, et al. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995; 87:1846.
  34. van den, Brandt PA, Spiegelman, D, Yaun, SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152:514.
  35. Lahmann, PH, Hoffmann, K, Allen, N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111:762.
  36. Eliassen, AH, Colditz, GA, Rosner, B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006; 296:193.
  37. Morimoto, LM, White, E, Chen, Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13:741.
  38. Feigelson, HS, Jonas, CR, Teras, LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004; 13:220.
  39. Ahn, J, Schatzkin, A, Lacey, JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167:2091.
  40. Hankinson, SE, Willett, WC, Manson, JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995; 87:1297.
  41. Gunter, MJ, Hoover, DR, Yu, H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101:48.
  42. Key, TJ, Pike, MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24:29.
  43. Michels, KB, Terry, KL, Willett, WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166:2395.
  44. Potischman, N, Swanson, CA, Siiteri, PK, Hoover, RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996; 88:756.
  45. Terry, KL, Willett, WC, Rich-Edwards, JW, et al. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 2006; 166:2484.
  46. Ahlgren, M, Melbye, M, Wohlfahrt, J, Sorensen, TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004; 351:1619.
  47. Maruti, SS, Willett, WC, Feskanich, D, et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008; 100:728.
  48. Bernstein, L, Patel, AV, Ursin, G, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005; 97:1671.
  49. Dallal, CM, Sullivan-Halley, J, Ross, RK, et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 2007; 167:408.
  50. Margolis, KL, Mucci, L, Braaten, T, et al. Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev 2005; 14:27.
  51. Mertens, AJ, Sweeney, C, Shahar, E, et al. Physical activity and breast cancer incidence in middle-aged women: a prospective cohort study. Breast Cancer Res Treat 2006; 97:209.
  52. McTiernan, A, Kooperberg, C, White, E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 2003; 290:1331.
  53. Patel, AV, Callel, EE, Bernstein, L, et al. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control 2003; 14:519.
  54. Bardia, A, Hartmann, LC, Vachon, CM, et al. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med 2006; 166:2478.
  55. Willett, WC, Rockhill, B, Hankinson, SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, Harris, JR, Lippman, ME, Morrow, M, Osborne, CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004, 3rd ed, p.253.
  56. Thune, I, Brenn, T, Lund, E, Gaard, M. Physical activity and the risk of breast cancer. N Engl J Med 1997; 336:1269.
  57. Brinton, LA, Bernstein, L, Colditz, GA. Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997. Cancer 1998; 83:595.
  58. Friedenreich, CM, Bryant, HE, Courneya, KS. Case-control study of lifetime physical activity and breast cancer risk. Am J Epidemiol 2001; 154:336.
  59. Yang, D, Bernstein, L, Wu, AH. Physical activity and breast cancer risk among Asian-American women in Los Angeles: a case-control study. Cancer 2003; 97:2565.
  60. Lee, IM, Cook, NR, Rexrode, KM, Buring, JE. Lifetime physical activity and risk of breast cancer. Br J Cancer 2001; 85:962.
  61. McTiernan, A, Tworoger, SS, Ulrich, CM, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004; 64:2923.
  62. Willett, WC, Rockhill, B, Hankinson, SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, Harris, JR, Lippman, ME, Morrow, M, Osborne, CK (Eds), Lippincott, Williams and Wilkins, Philadelphia, 2004, pp. 246-249.
  63. Willett, WC, Diet and cancer:one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 2001; 10:3.
  64. Armstrong, B, Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15:617.
  65. Hunter, DJ, Spiegelman, D, Adami, H, et al. Cohort studies of fat intake and the risk of breast cancer — a pooled analysis. N Engl J Med 1996; 334:356.
  66. Cho, E, Spiegelman, D, Hunter, DJ, et al. Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 2003; 95:1079.
  67. Boyd, NF, Stone, J, Vogt, KN, et al. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003; 89:1672.
  68. Mattisson, I,Wirfalt, E, Johansson, U, et al. Intakes of plant fibre and fat and risk of breast cancer--a prospective study in the Malmo Diet and Cancer cohort. Br J Cancer 2004; 90:122.
  69. Prentice, RL, Caan, B, Chlebowski, RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:629.
  70. Thiebaut, AC, Kipnis, V, Chang, SC, et al. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007; 99:451.
  71. Holmes, MD, Hunter, DJ, Colditz, GA, et al. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 1999; 281:914.
  72. Kim, EH, Willett, WC, Colditz, GA, et al. Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up. Am J Epidemiol 2006; 164:990.
  73. Cho, E, Chen, WY, Hunter, DJ, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006; 166:2253.
  74. Taylor, EF, Burley, VJ, Greenwood, DC, Cade, JE. Meat consumption and risk of breast cancer in the UK Women's Cohort Study. Br J Cancer 2007; 96:1139.
  75. Shin, MH, Holmes, MD, Hankinson, SE, et al. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 2002; 94:1301.
  76. Knekt, P, Jarvinen, R, Seppanen, R, et al. Intake of dairy products and the risk of breast cancer. Br J Cancer 1996; 73:687.
  77. Boyd, NF, Martin, LJ, Noffel, M, et al. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 1993; 68:627.
  78. Lin, J, Manson, JE, Lee, IM, et al. Intakes of calcium and vitamin d and breast cancer risk in women. Arch intern Med 2007; 167:1050.
  79. Missmer, SA, Smith-Warner, SA, Spiegelman, D, et al. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol 2002; 31:78.
  80. Chlebowski, RT, Johnson, KC, Kooperberg, C, et al. Calcium plus vitamin d supplementation and the risk of breast cancer. J Natl Cancer Inst 2008; 100:1581.
  81. Trock, BJ, Hilakivi-Clarke, L, Clarke, R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98:459.
  82. Wu, AH, Yu, MC, Tseng, CC, Pike, MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98:9.
  83. Messina, M, McCaskill-Stevens, W, Lampe, JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 2006; 98:1275.
  84. Verheus, M, van Gils, CH, Keinan-Boker, L, et al. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007; 25:648.
  85. Grace, PB, Taylor, JI, Low, YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004; 13:698.
  86. Piller, R, Chang-Claude, J, Linseisen, J. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 2006; 15:225.
  87. Iwasaki, M, Inoue, M, Otani, T, et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 2008; 26:1677.
  88. Touillaud, MS, Thiebaut, AC, Fournier, A, et al. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 2007; 99:475.
  89. Hsieh, CY, Santell, RC, Haslam, SZ, Helferich, WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58:3833.
  90. Zava, DT, Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997; 27:31.
  91. Kuiper, GG, Lemmen, JG, Carlsson, B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139:4252.
  92. Lin, J, Cook, NR, Albert, C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101:14.
  93. Nagel, G, Linseisen, J, van Gils, CH, et al. Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)Breast Cancer Res Treat 2010; 119:1573.
  94. Kushi, LH, Fee, RM, Sellers, TA, et al. Intake of vitamins A, C,and E and postmenopausal breast cancer. Am J Epidemiol 1996; 144:165.
  95. Lopez-Saez, JB, Senra-Varela, A, Pousa-Estevez, L. Selenium in breast cancer. Oncology 2003; 64:227.
  96. Ganmaa, D, Willett, WC, Li, TY, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008; 122:2071.
  97. Ishitani, K, Lin, J, Manson, JE, et al. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 2008; 168:2022.
  98. Band, P, Le, N, Fang, R, Deschamps, M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002; 360:1044.
  99. Hamajima, N, Hirose, K, Tajima, K, et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002; 87:1234.
  100. Chaturvedi, P. Does smoking increase the risk of breast cancer?. Lancet Oncol 2003; 4:657.
  101. Reynolds, P, Hurley, S, Goldberg, DE, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004; 96:29.
  102. Cui, Y, Miller, AB, Rohan, TE. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat 2006; 100:293.
  103. Al-Delaimy, WK, Cho, E, Chen, WY, et al. A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 2004; 13:398.
  104. Lissowska, J, Brinton, LA, Zatonski, W, et al. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 2006; 119:1961.
  105. McElroy, JA, Shafer, MM, Trentham-Dietz, A, et al. Cadmium exposure and breast cancer risk. J Natl Cancer Inst 2006; 98:869.
  106. Miller, MD, Marty, MA, Broadwin, R, et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med 2007; 44:93.
  107. Clemons, M, Goss, P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344:276.
  108. Kelsey, JL, Gammon, MD, John, EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36.
  109. MacMahon, B, Trichopoulos, D, Brown, J, et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer 1982; 30:427.
  110. Hsieh, C-C, Trichopoulos, D, Katsouyanni, K, et al. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990; 46:796.
  111. Colditz, GA, Rosner, B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000; 152:950.
  112. Hamilton, AS, Mack, TM. Puberty and genetic susceptibility to breast cancer in a case-control study in twins. N Engl J Med 2003; 348:2313.
  113. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350:1047.
  114. Brinton, LA, Schairer, C, Hoover, RN, Fraumeni, JF Jr. Menstrual factors and risk of breast cancer. Cancer Invest 1988; 6:245.
  115. Gammon, MD, Thompson, WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990; 132:708.
  116. Rossing, MA, Daling, JR, Weiss, NS, et al. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 1996; 60:3.
  117. Modan, B, Ron, E, Lerner-Geva, L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147:1038.
  118. Brinton, LA, Melton LJ, 3rd, Malkasian, GD Jr, et al. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129:712.
  119. Rosner, B, Colditz, GA, Willett, WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am J Epidemiol 1994; 139:819.
  120. Bruzzi, P, Negri, E, La Vecchia, C, et al. Short term increase in risk of breast cancer after full term pregnancy. BMJ 1988; 297:1096.
  121. Colditz, GA, Frazier, AL. Models of breast cancer show that risk is set by events of early life: Prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995; 4:567.
  122. Beral, V, Bull, D, Doll, R, et al. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 2004; 363:1007.
  123. Melbye, M, Wohlfahrt, J, Olsen, JH, et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997; 336:81.
  124. Erlandsson, G, Montgomery, SM, Cnattingius, S, Ekbom, A. Abortions and breast cancer: record-based case-control study. Int J Cancer 2003; 103:676.
  125. Paoletti, X, Clavel-Chapelon, F. Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study. Int J Cancer 2003; 106:270.
  126. Reeves, GK, Kan, SW, Key, T, et al. Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer 2006; 119:1741.
  127. Michels, KB, Xue, F, Colditz, GA, Willett, WC. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 2007; 167:814.
  128. Stuebe, AM, Willett, WC, Xue, F, Michels, KB. Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med 2009; 169:1364.
  129. Zheng, T, Holford, TR, Mayne, ST, et al. Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer 2001; 84:1472.
  130. Tryggvadottir, L, Tulinius, H, Eyfjord, JE, Sigurvinsson, T. Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol 2001; 154:37.
  131. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360:187.
  132. Jernstrom, H, Lubinski, J, Lynch, HT, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004; 96:1094.
  133. Martin, RM, Middleton, N, Gunnell, D, et al. Breast-feeding and cancer: the Boyd Orr cohort and a systematic review with meta-analysis. J Natl Cancer Inst 2005; 97:1446.
  134. Key, TJ, Appleby, PN, Reeves, GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218.
  135. Hankinson, SE, Willett, WC, Manson, JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90:1292.
  136. Key, T, Appleby, P, Barnes, I, Reeves, G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606.
  137. Lippman, ME, Krueger, KA, Eckert, S, et al. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 2001; 19:3111.
  138. Cauley, JA, Lucas, FL, Kuller, LH, et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1999; 130:270.
  139. Missmer, SA, Eliassen, AH, Barbieri, RL, Hankinson, SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004; 96:1856.
  140. Beattie, MS, Costantino, JP, Cummings, SR, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst 2006; 98:110.
  141. Kaaks, R, Berrino, F, Key, T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005; 97:755.
  142. Thomas, HV, Key, TJ, Allen, DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997; 75:1075.
  143. Wysowski, DK, Comstock, GW, Helsing, KJ, Lau, HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125:791.
  144. Helzlsouer, KJ, Alberg, AJ, Bush, TL, et al. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994; 18:79.
  145. Rosenberg, CR, Pasternack, BS, Shore, RE, et al. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 1994; 140:518.
  146. Kabuto, M, Akiba, S, Stevens, RG, et al. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 2000; 9:575.
  147. Travis, RC, Key, TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res 2003; 5:239.
  148. Eliassen, AH, Missmer, SA, Tworoger, SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98:1406.
  149. Cummings, SR, Tice, JA, Bauer, S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009; 101:384.
  150. Tworoger, SS, Missmer, SA, Eliassen, AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15:967.
  151. Zmuda, JM, Cauley, JA, Ljung, BM, et al. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 2001; 93:930.
  152. Zhang, Y, Kiel, DP, Kreger, BE, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997; 336:611.
  153. Cauley, JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women. JAMA 1996; 276:1404.
  154. Chen, Z, Arendell, L, Aickin, M, et al. Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer 2008; 113:907.
  155. Tworoger, SS, Sluss, P, Hankinson, SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 2006; 66:2476.
  156. Renehan, AG, Zwahlen, M, Minder, C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363:1346.
  157. Sugumar, A, Liu, YC, Xia, Q, et al. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 2004; 111:293.
  158. Shi, R, Yu, H, McLarty, J, Glass, J. IGF-I and breast cancer: a meta-analysis. Int J Cancer 2004; 111:418.
  159. Fletcher, O, Gibson, L, Johnson, N, et al. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:2.
  160. Baglietto, L, English, DR, Hopper, JL, et al. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:763.
  161. Schernhammer, ES, Holly, JM, Hunter, DJ, et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 2006; 13:583.
  162. Michels, KB, Solomon, CG, Hu, FB, Rosner, BA. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 2003; 26:1752.
  163. Baron, JA, Weiderpass, E, Newcomb, PA, et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001; 12:875.
  164. Talamini, R, Franceschi, S, Favero, A, et al. Selected medical conditions and risk of breast cancer. Br J Cancer 1997; 75:1699.
  165. Lipscombe, LL, Goodwin, PJ, Zinman, B, et al. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 2006; 98:349.
  166. Larsson, SC, Mantzoros, CS, Wolk, A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121:856.
  167. Weiss, HA, Brinton, LA, Potischman, NA, Brogan, D. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999; 28:816.
  168. Sellers, TA, Sprafka, JM, Gapstur, SM, Rich, SS. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?. Epidemiology 1994; 5:102.
  169. Hjalgrim, H, Frisch, M, Ekbom, A, et al. Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997; 241:471.
  170. Inoue, M, Iwasaki, M, Otani, T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166:1871.
  171. Wolf, I, Sadetzki, S, Catane, R, et al. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6:103.
  172. Boyd, NF, Dite, GS, Stone, J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347:886.
  173. Vachon, CM, Sellers, TA, Carlson, EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007; 67:8412.
  174. Irwin, ML, Aiello, EJ, McTiernan, A, et al. Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol 2007; 25:1061.
  175. Boyd, NF, Greenberg, C, Lockwood, G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 1997; 89:488.
  176. Boyd, NF, Guo, H, Martin, LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227.
  177. Boyd, NF, Rommens, JM, Vogt, K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6:798.
  178. McCormack, VA, dos Santos, Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159.
  179. Kerlikowske, K, Ichikawa, L, Miglioretti, DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007; 99:386.
  180. Kopans, DB. Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk. Radiology 2008; 246:348.
  181. Ziv, E, Tice, J, Smith-Bindman, R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13:2090.
  182. Kerlikowske, K, Shepherd, J, Creasman, J, et al. Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst 2005; 97:368.
  183. Tamimi, RM, Byrne, C, Colditz, GA, Hankinson, SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007; 99:1178.
  184. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996; 347:1713.
  185. Hankinson, SE, Colditz, GA, Manson, JE, et al. A prospective study of oral contraceptive use and risk of breast cancer. Cancer Causes Control 1997; 8:65.
  186. Marchbanks, PA, McDonald, JA, Wilson, HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002; 346:2025.
  187. Chlebowski, RT, Hendrix, SL, Langer, RD, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial. JAMA 2003; 289:3243.
  188. Calle, EE, Feigelson, HS, Hildebrand, JS, et al. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype. Cancer 2009; 115:936.
  189. Anderson, GL, Limacher, M, Assaf, AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701.
  190. Gail model available online at http://www.cancer.gov/bcrisktool/.
  191. Gail, MH, Costantino, JP, Pee, D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007; 99:1782. The tool can be accessed online at www.cancer.gov/bcrisktool/.
  192. Chen, J, Pee, D, Ayyagari, R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006; 98:1215.
  193. Barlow, WE, White E, Ballard-Barbash, R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006; 98:1204.
  194. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389.
  195. Lichtenstein, P, Holm, NV, Verkasalo, PK, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78.
  196. Henderson, TO, Amsterdam, A, Bhatia, S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152:444.
  197. Kenney, LB, Yasui, Y, Inskip, PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141:590.
  198. Guibout, C, Adjadj, E, Rubino, C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005; 23:197.
  199. Pukkala, E, Kesminiene, A, Poliakov, S, et al. Breast cancer in Belarus and Ukraine after the Chernobyl accident. Int J Cancer 2006; 119:651.
  200. Ostroumova, E, Preston, DL, Ron, E, et al. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004. Br J Cancer 2008; 99:1940.
  201. John, EM, Kelsey, JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993; 15:157.
  202. Hoffman, DA, Lonstein, JE, Morin, MM, et al. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989; 81:1307.
  203. Dutkowsky, JP, Shearer, D, Schepps, B, et al. Radiation exposure to patients receiving routine scoliosis radiography measured at depth in an anthropomorphic phantom. J Pediatr Orthop 1990; 10:532.
  204. Ronckers, CM, Erdmann, CA, Land, CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005; 7:21.
  205. John, EM, Phipps, AI, Knight, JA, et al. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer 2007; 121:386.
  206. Calle, EE, Frumkin, H, Henley, SJ, et al. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52:301.
  207. Willett, WC, Rockhill, B, Hankinson, SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, Harris, JR, Lippman, ME, Morrow, M, Osborne, CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.255.
  208. Lipworth, L, Tarone, RE, Friis, S, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 2009; 124:490.
  209. Hansen, J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001; 12:74.
  210. Schernhammer, ES, Laden, F, Speizer, FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001; 93:1563.
  211. Megdal, SP, Kroenke, CH, Laden, F, et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005; 41:2023.
  212. Davis, S, Mirick, DK, Stevens, RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001; 93:1557.
  213. Schernhammer, ES, Hankinson, SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005; 97:1084.
  214. Schernhammer, ES, Berrino, F, Krogh, V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008; 100:898.
  215. http://monographs.iarc.fr/ENG/Meetings/vol98-pressrelease.pdf (Accessed October 14, 2009).
  216. Straif, K, Baan, R, Grosse, Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8:1065.
  217. Cook, NR, Lee, IM, Gaziano, JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294:47.
  218. Takkouche, B, Regueira-Mendez, C, Etminan, M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 2008; 100:1439.
  219. Velicer, CM, Heckbert, SR, Lampe, JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA 2004; 291:827.
  220. Sorensen, HT, Skriver, MV, Friis, S, et al. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005; 92:594.
  221. Garcia Rodriguez, LA, Gonzalez-Perez, A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005; 161:616.
  222. Didham, RC, Reith, DM, McConnell, DW, Harrison, KS. Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat 2005; 92:163.
  223. Larsson, SC, Giovannucci, E, Wolk, A. Folate and Risk of Breast Cancer: A Meta-analysis. J Natl Cancer Inst 2007; 99:64.
Epidemiology and risk factors for breast cancer Cephalosporins Neuroleptic malignant syndrome Patient information: Cushing's syndrome Search on "ALL in children" Search on "Thromboangiitis%20obliterans" Management of benign esophageal strictures